Why Medication-Assisted Treatment Matters Behind Bars

Medication-assisted treatment, often called MAT or more broadly medications for opioid use disorder, is one of the most important tools in modern addiction care. In correctional settings, it can help people who enter jail or prison with opioid use disorder stay stable, avoid dangerous withdrawal, and continue treatment after release. That matters because incarceration can interrupt care at exactly the moment when continuity is most needed.

In Massachusetts, this issue is not just a policy debate. It is part of the state's correctional health system, budget planning, and public health strategy. The state has taken a relatively active approach compared with many other jurisdictions, especially in county correctional facilities and in state prison settings where re-entry planning is tied to treatment access. ([malegislature.gov](https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXVIII/Chapter127/Section17B))

What MAT Means in a Jail or Prison Setting

MAT combines medication with behavioral health services. In practice, that usually means medications such as methadone, buprenorphine, or naltrexone, along with counseling, care coordination, and discharge planning. SAMHSA describes correctional MAT as a structured approach that can be implemented in jails and prisons to support people with opioid use disorder. ([samhsa.gov](https://www.samhsa.gov/resource/ebp/medication-assisted-treatment-mat-opioid-use-disorder-jails-prisons-planning))

In a correctional environment, the goal is not only symptom control. It is also to reduce withdrawal, lower the risk of relapse, and improve the chance that a person can continue treatment after release. That re-entry piece is especially important because overdose risk rises sharply after incarceration if treatment is interrupted. This is one reason Massachusetts has built reporting and funding structures around correctional MAT. ([malegislature.gov](https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXVIII/Chapter127/Section17d))

Massachusetts Law and Policy: A Stronger Framework Than Many States

Massachusetts law requires the Department of Correction to offer medication-assisted treatment in certain circumstances and to maintain the capacity to possess, dispense, and administer FDA-approved medications for opioid use disorder in specified facilities. The statute also ties treatment to re-entry planning, including the final 90 days of a sentence in some cases. ([malegislature.gov](https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXVIII/Chapter127/Section17B))

The state also has a formal medication-assisted treatment policy in the Massachusetts Trial Court system, which defines MAT as medication combined with behavioral health services. While that policy is not the same as a jail or prison treatment rule, it reflects how Massachusetts has normalized MAT across parts of the justice system. ([mass.gov](https://www.mass.gov/info-details/medication-assisted-treatment-policy))

County Jails in Massachusetts Have Become a Major Focus

One of the most notable developments in Massachusetts has been the expansion of MAT in county correctional facilities. The FY 2026 enacted budget includes a specific line item for "Medically-Assisted Treatment at County Correctional Facilities," with $18.5 million appropriated. That budget line shows that the state is still treating jail-based MAT as an ongoing operational priority rather than a short-term pilot. ([budget.digital.mass.gov](https://budget.digital.mass.gov/summary/fy26/enacted/administration-and-finance/administration-and-finance/15990105/))

Federal civil rights enforcement also helped shape the landscape. The U.S. Attorney's Office for the District of Massachusetts announced that correctional facilities statewide would maintain all medications used to treat opioid use disorder for people already in treatment before incarceration, describing Massachusetts as one of the few states where every correctional facility at the state, local, and federal level is or will soon be maintaining all forms of MOUD for incarcerated people. ([justice.gov](https://www.justice.gov/usao-ma/pr/us-attorney-rollins-announces-correctional-facilities-statewide-maintain-all-medications))

What the Data Suggests

Massachusetts has required reporting on MAT costs, treatment types, continuity of care, and re-entry outcomes for facilities covered by the statute. Those reporting requirements are important because they push the system to measure not just whether medication is available, but whether people continue treatment before release and after discharge. ([malegislature.gov](https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXVIII/Chapter127/Section17d))

Recent research has also examined the Massachusetts county jail model. A New England Journal of Medicine study reported that in 2019, seven county correctional facilities in Massachusetts initiated pilot programs to provide all FDA-approved medications for opioid use disorder, and it followed outcomes after release. The study found that post-release engagement was not perfect, which underscores a key point: starting treatment in jail helps, but continuity in the community remains essential. ([nejm.org](https://www.nejm.org/doi/full/10.1056/NEJMsa2415987))

Why Re-Entry Planning Is the Real Test

For people leaving jail or prison, the transition back to the community is often the most fragile period. Massachusetts law recognizes this by requiring re-entry treatment plans in certain state correctional settings and by linking MAT to discharge preparation. The state's inmate healthcare materials also emphasize individualized treatment plans and continuity of care. ([malegislature.gov](https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXVIII/Chapter127/Section17B))

In practical terms, a strong re-entry plan may include:

• confirming the medication a person was receiving before incarceration,
• arranging a community prescriber or opioid treatment program,
• coordinating MassHealth or other insurance coverage,
• providing enough medication to bridge the gap after release, and
• connecting the person to counseling, primary care, and recovery supports. ([malegislature.gov](https://malegislature.gov/Laws/GeneralLaws/PartI/TitleXVIII/Chapter127/Section17d))

Challenges That Still Remain

Even in a state with relatively strong policy support, correctional MAT is not simple. Facilities must manage security, staffing, medication storage, clinical evaluation, consent, and coordination with outside providers. They also have to balance treatment access with the realities of jail turnover, short stays, and the administrative burden of re-entry planning. SAMHSA's correctional toolkit exists because implementation is complex, even when the clinical case is clear. ([samhsa.gov](https://www.samhsa.gov/resource/ebp/medication-assisted-treatment-mat-opioid-use-disorder-jails-prisons-planning))

Another challenge is that access does not automatically equal continuity. A person may start or continue medication in custody and still struggle to stay engaged after release. That is why Massachusetts' approach increasingly emphasizes both in-custody treatment and post-release linkage. The research and the state reporting requirements point in the same direction: the handoff matters as much as the medication itself. ([nejm.org](https://www.nejm.org/doi/full/10.1056/NEJMsa2415987))

What Makes Massachusetts Stand Out in 2026

As of today, Massachusetts stands out because it combines law, budget support, correctional policy, and public health oversight. The state has a dedicated budget reserve for county correctional MAT, statutory reporting requirements for correctional facilities, and correctional healthcare policies that support medication continuity. That combination makes Massachusetts one of the more developed state models for jail- and prison-based opioid use disorder treatment. ([budget.digital.mass.gov](https://budget.digital.mass.gov/summary/fy26/enacted/administration-and-finance/administration-and-finance/15990105/))

Still, the most important takeaway is not that Massachusetts has solved the problem. It has not. The more accurate conclusion is that the state has built a serious framework for treating opioid use disorder in custody and for trying to reduce the harm that often follows release. For families, advocates, clinicians, and correctional leaders, that framework offers a practical lesson: when jails and prisons treat addiction as a medical condition, they can improve safety, continuity, and the chance of recovery. ([justice.gov](https://www.justice.gov/usao-ma/pr/us-attorney-rollins-announces-correctional-facilities-statewide-maintain-all-medications))

Other Relevant Articles for Massachusetts

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate